Arrow Ventures is a specialist venture capital firm dedicated to veterinary therapeutics.

We invest in innovative animal health companies through equity investments, combining capital with deep operational expertise in drug development, regulatory strategy, CMC, clinical development and commercialisation. Arrow also licenses promising veterinary technologies directly from universities and research organisations, advancing them through in-house development to create high-value pharmaceutical assets.

While our primary focus is developing companion animal and livestock therapeutics for regulatory in USA, our portfolio companies are global.

Business Type

Investor